Adimab, LLC is 10% at Adagio Therapeutics, Inc. (ADGI). They have made 1 open-market trade across 1 company since 2024, most recently 2024-01-19.
CIK 0001545672
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IVVD | SELL | 2024-01-19 | 2024-01-22 | $3.95 | $19.8M | +7.1% | -10.9% | -51.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.